Zydus Life stock price jumps 6% on USFDA nod for Valsartan tablets 0 24.07.2024 12:03 Business Standard The shares surged after the pharmaceutical major announced that it has secured final nod from United States Food and Drug Administration (USFDA) for Valsartan tablets. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
